Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell, Marginal Zone × Interleukin-2 × 30 days × Clear all

Sponsor

Conditions

Melanoma 4 Ovarian Neoplasms 3 Leukemia, Myeloid, Acute 3 Recurrence 2 Neoplasm Metastasis 2 Lymphoma 2 Leukemia 2 Carcinoma, Non-Small-Cell Lung 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Dysplasia 1 Stomach Neoplasms 1 Sarcoma 1 Prostatic Neoplasms 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Neoplasms 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Meningeal Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphoma, B-Cell 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia, Myeloid 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Head and Neck Neoplasms 1

Interventions

Rituximab 11 Cyclophosphamide 7 Lenalidomide 5 zanubrutinib 4 venetoclax 4 Vincristine 4 orelabrutinib 3 fludarabine 3 Prednisone 3 Doxorubicin 3 CT-P10 3 pirtobrutinib 2 obinutuzumab 2 fludarabine phosphate 2 Whole-Body Irradiation 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 Cyclosporine 2 voruciclib 1 treosulfan 1 tislelizumab 1 prednylidene 1 pembrolizumab 1 ixazomib 1 ibrutinib 1 glofitamab 1 deltacortene 1 cc-486 1 Stem Cell Transplantation 1 Radiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡